An outbreak investigation team in a district in Maharashtra identifies 47 cases of mumps in a single school over 2 weeks. The attack rate is highest among children aged 8–12 years. Vaccination records show that 62% of affected children had received one dose of MMR vaccine, and 18% had received two doses. The remaining 20% were unvaccinated. What is the most likely explanation for this outbreak pattern despite significant vaccine coverage?

Explanation

## Outbreak Epidemiology Analysis ### Key Observations from the Vignette **High-Yield:** Despite 80% of affected children having received at least one MMR dose, mumps transmission occurred. This is a classic pattern of **secondary vaccine failure** in a population with incomplete vaccination coverage. ### MMR Vaccine Efficacy and Dose Response | Vaccine Component | One Dose Efficacy | Two Doses Efficacy | Notes | |---|---|---|---| | **Measles** | 93% | 97% | High efficacy even with 1 dose | | **Mumps** | 78–88% | 88–95% | **Lowest efficacy of MMR components** | | **Rubella** | 97% | >99% | Highest efficacy | **Key Point:** Mumps vaccine has the **lowest efficacy** among MMR components. One dose provides only 78–88% protection, leaving 12–22% of vaccinated individuals susceptible. ## Why This Outbreak Occurred ### Mechanism of Secondary Vaccine Failure 1. **Incomplete vaccination coverage in the cohort:** - 62% with 1 dose = ~15–20% susceptible to mumps despite vaccination - 20% unvaccinated = 100% susceptible - **Total susceptible population ≈ 30–35%** (sufficient for outbreak) 2. **Single-dose immunity is insufficient:** - Many children in the 8–12 age group received only one MMR dose (older immunization schedule) - Two-dose schedule became standard only after ~2010 in India - Only 18% of affected children had received two doses 3. **Mumps is highly contagious:** - R₀ (basic reproduction number) = 4–7 - In a school setting with 30–35% susceptible individuals, sustained transmission is possible **Clinical Pearl:** Mumps outbreaks in vaccinated populations are well-documented and occur when: - One-dose coverage is high but two-dose coverage is low - The cohort contains children vaccinated under older schedules - Vaccine efficacy for mumps (78–88%) is lower than for measles (93%) or rubella (97%) ### Why the Age Group 8–12 Years? **High-Yield:** Children aged 8–12 in 2024 were born around 2012–2016. During this period: - India's routine immunization schedule included **one dose of MMR** (at 9–12 months) - Two-dose MMR was introduced later (second dose at 16–24 months in some states) - Many children in this cohort received only one dose ## Differential Diagnosis: Why Other Options Are Wrong ### Option A: Primary Vaccine Failure (Defective Batch) **Why unlikely:** - Primary vaccine failure would affect **all vaccinated children equally** - We would expect 100% attack rate in vaccinated group - The pattern shows 62% of cases were vaccinated (not 0%), indicating partial protection - A defective batch would be detected through quality assurance; India's vaccine cold chain is monitored ### Option B: Waning Immunity + Vaccine-Escape Mutant **Why less likely:** - Waning immunity typically occurs **years after vaccination**, not in children vaccinated 8–12 years ago (who are now 8–12 years old) - Vaccine-escape mumps mutants are **rare and not documented** in India - The outbreak pattern is explained by **single-dose immunity**, not waning or escape ### Option D: Nosocomial Transmission **Why unlikely:** - Outbreak is in a **school**, not a healthcare facility - No mention of healthcare worker exposure - School outbreaks are typical of community transmission, not nosocomial spread - Attack rate pattern (highest in 8–12 age group) fits community exposure, not healthcare-associated ## Public Health Implications **Key Point:** This outbreak highlights the importance of **two-dose MMR vaccination** and **catch-up campaigns** in older cohorts who received only one dose. ### Recommended Response 1. **Immediate:** Isolation of confirmed cases, symptomatic management 2. **Short-term:** Vaccination of unvaccinated and single-dose vaccinated children in the school 3. **Long-term:** Review state immunization schedules to ensure two-dose MMR coverage **Mnemonic:** **MUMPS Outbreak in Vaccinated Population = Secondary Vaccine Failure** (SVF) - **S**ingle-dose immunity insufficient - **V**accine efficacy for mumps lower (78–88%) - **F**ailure to achieve two-dose coverage